Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.

Shimoi T, Shibata N, Kitada M, Tsuneizumi M, Yamamoto M, Ozaki Y, Fujimoto Y, Akiyoshi S, Hashimoto N, Yamaguchi M, Yamamoto Y, Masuda N, Tada H, Yamanaka T, Kikawa Y, Taira T, Nakagawa S, Takahashi T, Oba MS, Niikura N.

Open source

DOI: 10.1038/s41523-026-00997-y
Published: 2026-06-26
Container: NPJ Breast Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41523-026-00997-y,
  title = {Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.},
  author = {Shimoi T and  Shibata N and  Kitada M and  Tsuneizumi M and  Yamamoto M and  Ozaki Y and  Fujimoto Y and  Akiyoshi S and  Hashimoto N and  Yamaguchi M and  Yamamoto Y and  Masuda N and  Tada H and  Yamanaka T and  Kikawa Y and  Taira T and  Nakagawa S and  Takahashi T and  Oba MS and  Niikura N.},
  year = {2026},
  journal = {NPJ Breast Cancer},
  doi = {10.1038/s41523-026-00997-y},
  url = {https://doi.org/10.1038/s41523-026-00997-y}
}

RIS

TY  - JOUR
TI  - Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.
AU  - Shimoi T
AU  -  Shibata N
AU  -  Kitada M
AU  -  Tsuneizumi M
AU  -  Yamamoto M
AU  -  Ozaki Y
AU  -  Fujimoto Y
AU  -  Akiyoshi S
AU  -  Hashimoto N
AU  -  Yamaguchi M
AU  -  Yamamoto Y
AU  -  Masuda N
AU  -  Tada H
AU  -  Yamanaka T
AU  -  Kikawa Y
AU  -  Taira T
AU  -  Nakagawa S
AU  -  Takahashi T
AU  -  Oba MS
AU  -  Niikura N.
PY  - 2026
JO  - NPJ Breast Cancer
DO  - 10.1038/s41523-026-00997-y
UR  - https://doi.org/10.1038/s41523-026-00997-y
ER  -

APA

T, S., N, S., M, K., M, T., M, Y., Y, O., Y, F., S, A., N, H., M, Y., Y, Y., N, M., H, T., T, Y., Y, K., T, T., S, N., T, T., MS, O., & N., N. (2026). Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.. NPJ Breast Cancer. https://doi.org/10.1038/s41523-026-00997-y

Source records

europe-pmc · retrieved 2026-09-26T23:58:04.481Z